MoonLake Immunotherapeutics (MLTX) Q3 2025 Earnings

Aug 5Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.87
-0.73
-0.58
-0.44

Details

Expected EPS
-0.74038
Actual EPS
-0.87
Surprise EPS
-0.13
Surprise Percent
-17.51%

Description

⁨MoonLake Immunotherapeutics⁩ (⁦MLTX⁩) has reported earnings of ⁦-0.87⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts